Justis P. Ehlers, MD

Appointed
2010

Education & Fellowships

Fellowship - Duke University Medical Center
Vitreoretinal Surgery
Durham, NC USA
2010

Residency - Wills Eye Hospital
Ophthalmology
Philadelphia, PA USA
2008

Internship - Saint Luke's Hospital
Preliminary Medicine
Chesterfield, MO USA
2005

Medical Education - Washington University School of Medicine
St. Louis, MO USA
2004

Undergraduate - University of Notre Dame
Notre Dame, IN USA
2000

Additional Training

Professional Highlights

• Co-chief Editor, Wills Eye Manual, 5th edition.
• Heed Fellow and Ronald G. Michels Fellow, Duke Eye Center
• Chief Resident, Wills Eye Institute
• Associate Editor, Retina, 2009-2010.

Certifications

• Ophthalmology

Specialty Interests

Diabetic retinopathy, macular degeneration, retinal detachment, retinal vein occlusions, macular holes, macular puckers and epiretinal membranes, eye injuries and ocular trauma, myopic degeneration, retinal artery occlusions, cystoid macular edema, histoplasmosis, choroidal neovascularization, retinal neovascularization, and other vitreoretinal diseases.Advanced vitreoretinal imaging, with particular interest in optical coherence tomography (OCT) and utilizing OCT in the operating room to improve our understanding of vitreoretinal surgical diseases and the ultrastructural impact of surgical maneuvers, to help guide surgical interventions and improve outcomes.

Awards & Honors

• Ronald G. Michels Fellowship Award, 2009
• Heed Fellowship Award, 2008
• Shipman Award, 2008
• Alpha Omega Alpha, 2003
• Senior Merit Scholar, 2003
• Phi Beta Kappa, 2000

Innovations & Patents

• Furthering the progress of the use of intraoperative optical coherence tomography (OCT) for the study of vitreoretinal surgical diseases and the impact of surgical manipulations on microstructural anatomy, such as with optic-pit related maculopathy.
• Development of the use of OCT contrast agents for enhanced visualization of tissue interfaces for ophthalmic applications of OCT imaging, including the development of “functional OCT” for incisional integrity assessment.
• Optimization and testing of OCT integration into the surgical microscope, allowing for real-time visualization of surgical maneuvers, characterization of intraocular instrumentations, and optimization of capturing OCT-visualized intraoperative motion.

Memberships

• American Society of Retina Specialists, 2008- present
• Society of Heed Fellows, 2008- present
• Wills Eye Hospital Society, 2008 - present
• Association for Research in Vision and Ophthalmology, 2006 - present
• American Academy of Ophthalmology, 2005 - present
• American Medical Association, 2003 - present

See publications for Justis P. Ehlers, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 9/7/2023, Dr. Ehlers has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Ehlers receives fees of $5,000 or more per year (or, in rare cases, equity or stock options) as a paid consultant, speaker or as a member of an advisory committee for the following companies:

• Apellis Pharmaceuticals, Inc.
• Novartis Pharmaceuticals Corporation
• Alcon, Inc.
• Adverum Biotechnologies, Inc.
• Carl Zeiss Meditec AG
• Beyeonics 
• Iveric bio, Inc.
• Roche (Hoffman-La Roche, Ltd.)
• Regeneron Pharmaceuticals, Inc.
• Boehringer Ingelheim
• Stealth BioTherapeutics Incorporated
• Regenxbio, Inc.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.